Genetesis is a privately held medical technology company oriented towards the development of efficient and non-invasive cardiac current density mapping. Our technology utilizes the body’s weak magnetic fields to reconstruct, computationally, areas of high and low electrical conductivity in the heart. Our software, the Genetesis CardioFlux Mapping System, is able to characterize deep sources of current that are consistently missed by the EKG, and does so with the utmost accuracy and predictiveness.

Genetesis is a privately held medical technology company oriented towards the development of efficient and non-invasive cardiac current density mapping. Our technology utilizes the body’s weak magnetic fields to reconstruct, computationally, areas of high and low electrical conductivity in the heart. Our software, the Genetesis CardioFlux Mapping System, is able to characterize deep sources of current that are consistently missed by the EKG, and does so with the utmost accuracy and predictiveness.

Blockchain technology addresses the trade-off between personalized care and operational costs by connecting the ecosystem to universal infrastructure. Shared infrastructure allows us to create global standards without compromising privacy and security.

Blockchain technology addresses the trade-off between personalized care and operational costs by connecting the ecosystem to universal infrastructure. Shared infrastructure allows us to create global standards without compromising privacy and security.